Stammdaten
Unternehmen
| Name | Kymera Therapeutics, Inc. |
|---|---|
| Ticker | KYMR |
| CIK | 0001815442 |
Branche
| SIC-Code | 2836 |
|---|---|
| Beschreibung | Biological Products, (No Diagnostic Substances) |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Kymera Therapeutics, Inc. |
Status
| Zuletzt geprüft | 2026-03-23 02:16:12.155172 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-20 | Esposito Pamela | Director | Open Market Sale | -600 | 79.24 | -47,546.34 | -1,8% | |
| 2026-03-20 | Esposito Pamela | Director | Open Market Sale | -700 | 77.71 | -54,397.77 | -2,0% | |
| 2026-03-20 | Esposito Pamela | Director | Open Market Sale | -1,200 | 79.94 | -95,933.04 | -3,6% | |
| 2026-03-11 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -11,111 | 83.72 | -930,207.36 | -34,8% | |
| 2026-03-11 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -12,882 | 83.10 | -1,070,510.95 | -40,1% | |
| 2026-03-11 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -1,765 | 82.13 | -144,955.04 | -5,4% | |
| 2026-03-04 | Jacobs Bruce N. | Officer, Chief Financial Officer | Open Market Sale | -2,519 | 85.04 | -214,206.69 | -8,0% | |
| 2026-03-04 | Jacobs Bruce N. | Officer, Chief Financial Officer | Open Market Sale | -447 | 86.62 | -38,721.24 | -1,5% | |
| 2026-03-04 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -394 | 84.00 | -33,094.62 | -1,2% | |
| 2026-03-04 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -2,017 | 85.04 | -171,518.42 | -6,4% | |
| 2026-03-04 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -1,150 | 85.78 | -98,647.81 | -3,7% | |
| 2026-03-04 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -358 | 86.62 | -31,011.64 | -1,2% | |
| 2026-03-04 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -492 | 84.00 | -41,326.28 | -1,5% | |
| 2026-03-04 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -2,519 | 85.04 | -214,206.69 | -8,0% | |
| 2026-03-04 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -1,437 | 85.78 | -123,266.87 | -4,6% | |
| 2026-03-04 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -447 | 86.62 | -38,721.24 | -1,5% | |
| 2026-03-04 | Jacobs Bruce N. | Officer, Chief Financial Officer | Open Market Sale | -492 | 84.00 | -41,326.28 | -1,5% | |
| 2026-03-04 | Jacobs Bruce N. | Officer, Chief Financial Officer | Open Market Sale | -1,437 | 85.78 | -123,266.87 | -4,6% | |
| 2026-03-02 | Booth Bruce | Director | Open Market Sale | -71,814 | 90.13 | -6,472,595.82 | -242,5% | |
| 2026-03-02 | Booth Bruce | Director | Open Market Sale | -10,052 | 90.13 | -905,986.76 | -33,9% | |
| 2026-03-02 | Booth Bruce | Director | Open Market Sale | -71,814 | 90.13 | -6,472,595.82 | -242,5% | |
| 2026-03-02 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -549 | 87.75 | -48,175.24 | -1,8% | |
| 2026-03-02 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -383 | 88.50 | -33,895.65 | -1,3% | |
| 2026-03-02 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -1,107 | 89.66 | -99,250.74 | -3,7% | |
| 2026-03-02 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -3,048 | 89.66 | -273,275.76 | -10,2% | |
| 2026-03-02 | Jacobs Bruce N. | Officer, Chief Financial Officer | Open Market Sale | -4,113 | 89.66 | -368,760.89 | -13,8% | |
| 2026-03-02 | Jacobs Bruce N. | Officer, Chief Financial Officer | Open Market Sale | -2,039 | 87.75 | -178,924.09 | -6,7% | |
| 2026-03-02 | Jacobs Bruce N. | Officer, Chief Financial Officer | Open Market Sale | -1,424 | 88.50 | -126,024.57 | -4,7% | |
| 2026-03-02 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -1,510 | 87.75 | -132,503.86 | -5,0% | |
| 2026-03-02 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -1,055 | 88.50 | -93,367.92 | -3,5% | |
| 2026-03-02 | Booth Bruce | Director | Open Market Sale | -71,814 | 90.13 | -6,472,595.82 | -242,5% | |
| 2026-03-02 | Booth Bruce | Director | Open Market Sale | -10,052 | 90.13 | -905,986.76 | -33,9% | |
| 2026-03-02 | Booth Bruce | Director | Open Market Sale | -10,052 | 90.13 | -905,986.76 | -33,9% | |
| 2026-02-25 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -1,501 | 92.81 | -139,307.81 | -5,2% | |
| 2026-02-25 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -5,434 | 90.39 | -491,179.26 | -18,4% | |
| 2026-02-25 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -19,764 | 89.78 | -1,774,411.92 | -66,5% | |
| 2026-02-25 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -8 | 93.49 | -747.92 | 0,0% | |
| 2026-02-25 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -3,293 | 91.76 | -302,165.68 | -11,3% | |
| 2026-02-20 | Esposito Pamela | Director | Open Market Sale | -1,900 | 87.06 | -165,410.01 | -6,2% | |
| 2026-02-20 | Esposito Pamela | Director | Open Market Sale | -600 | 88.10 | -52,860.00 | -2,0% | |
| 2026-01-20 | Esposito Pamela | Director | Open Market Sale | -200 | 68.52 | -13,704.00 | -0,5% | |
| 2026-01-20 | Esposito Pamela | Director | Open Market Sale | -400 | 66.68 | -26,672.00 | -1,0% | |
| 2026-01-20 | Esposito Pamela | Director | Open Market Sale | -4,900 | 67.99 | -333,145.12 | -12,5% | |
| 2025-12-31 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -6,014 | 78.52 | -472,211.46 | -17,7% | |
| 2025-12-31 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -23,986 | 77.95 | -1,869,727.89 | -70,0% | |
| 2025-12-17 | Esposito Pamela | Director | Open Market Sale | -7,959 | 82.34 | -655,361.57 | -24,5% | |
| 2025-12-17 | Esposito Pamela | Director | Open Market Sale | -4,099 | 83.45 | -342,064.42 | -12,8% | |
| 2025-12-17 | Esposito Pamela | Director | Open Market Sale | -1,000 | 84.07 | -84,070.00 | -3,1% | |
| 2025-12-17 | Esposito Pamela | Director | Open Market Sale | -14,505 | 81.56 | -1,182,984.29 | -44,3% | |
| 2025-12-12 | Booth Bruce | Director | Open Market Sale | -570 | 91.04 | -51,892.80 | -1,9% | |
| 2025-12-12 | Booth Bruce | Director | Open Market Sale | -108 | 91.04 | -9,832.32 | -0,4% | |
| 2025-12-12 | Booth Bruce | Director | Open Market Sale | -570 | 91.04 | -51,892.80 | -1,9% | |
| 2025-12-12 | Booth Bruce | Director | Open Market Sale | -570 | 91.04 | -51,892.80 | -1,9% | |
| 2025-12-12 | Booth Bruce | Director | Open Market Sale | -108 | 91.04 | -9,832.32 | -0,4% | |
| 2025-12-12 | Booth Bruce | Director | Open Market Sale | -108 | 91.04 | -9,832.32 | -0,4% | |
| 2025-12-11 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Open Market Purchase | 167,192 | 86.00 | 14,378,512.00 | +538,6% | |
| 2025-12-11 | Booth Bruce | Director | Open Market Sale | -976 | 91.23 | -89,040.48 | -3,3% | |
| 2025-12-11 | Booth Bruce | Director | Open Market Sale | -5,125 | 91.23 | -467,553.75 | -17,5% | |
| 2025-12-11 | Booth Bruce | Director | Open Market Sale | -976 | 91.23 | -89,040.48 | -3,3% | |
| 2025-12-11 | Booth Bruce | Director | Open Market Sale | -5,125 | 91.23 | -467,553.75 | -17,5% | |
| 2025-12-11 | Booth Bruce | Director | Open Market Sale | -976 | 91.23 | -89,040.48 | -3,3% | |
| 2025-12-11 | Booth Bruce | Director | Open Market Sale | -5,125 | 91.23 | -467,553.75 | -17,5% | |
| 2025-12-11 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Open Market Purchase | 1,838,621 | 86.00 | 158,121,406.00 | +5923,0% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -9,060 | 92.41 | -837,234.60 | -31,4% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -31,459 | 88.64 | -2,788,525.76 | -104,5% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -17,825 | 89.25 | -1,590,881.25 | -59,6% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -10,545 | 90.14 | -950,526.30 | -35,6% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -47,349 | 92.41 | -4,375,521.09 | -163,9% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -85,862 | 93.20 | -8,002,338.40 | -299,8% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -5,979 | 88.64 | -529,978.56 | -19,9% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -3,391 | 89.25 | -302,646.75 | -11,3% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -2,001 | 90.14 | -180,370.14 | -6,8% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -16,338 | 93.20 | -1,522,701.60 | -57,0% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -31,459 | 88.64 | -2,788,525.76 | -104,5% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -17,825 | 89.25 | -1,590,881.25 | -59,6% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -10,545 | 90.14 | -950,526.30 | -35,6% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -47,349 | 92.41 | -4,375,521.09 | -163,9% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -85,862 | 93.20 | -8,002,338.40 | -299,8% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -5,979 | 88.64 | -529,978.56 | -19,9% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -3,391 | 89.25 | -302,646.75 | -11,3% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -2,001 | 90.14 | -180,370.14 | -6,8% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -9,060 | 92.41 | -837,234.60 | -31,4% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -16,338 | 93.20 | -1,522,701.60 | -57,0% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -31,459 | 88.64 | -2,788,525.76 | -104,5% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -17,825 | 89.25 | -1,590,881.25 | -59,6% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -10,545 | 90.14 | -950,526.30 | -35,6% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -47,349 | 92.41 | -4,375,521.09 | -163,9% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -85,862 | 93.20 | -8,002,338.40 | -299,8% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -5,979 | 88.64 | -529,978.56 | -19,9% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -3,391 | 89.25 | -302,646.75 | -11,3% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -2,001 | 90.14 | -180,370.14 | -6,8% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -9,060 | 92.41 | -837,234.60 | -31,4% | |
| 2025-12-10 | Booth Bruce | Director | Open Market Sale | -16,338 | 93.20 | -1,522,701.60 | -57,0% | |
| 2025-12-08 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -3,300 | 91.46 | -301,830.87 | -11,3% | |
| 2025-12-08 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -1,400 | 92.19 | -129,066.00 | -4,8% | |
| 2025-12-08 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -100,000 | 89.17 | -8,917,000.00 | -334,0% | |
| 2025-12-08 | Albers Jeffrey W. | Director | Open Market Sale | -2,748 | 89.32 | -245,459.60 | -9,2% | |
| 2025-12-08 | Albers Jeffrey W. | Director | Open Market Sale | -2,252 | 90.30 | -203,363.48 | -7,6% | |
| 2025-12-08 | Albers Jeffrey W. | Director | Open Market Sale | -2,748 | 89.32 | -245,459.60 | -9,2% | |
| 2025-12-08 | Albers Jeffrey W. | Director | Open Market Sale | -2,252 | 90.30 | -203,363.48 | -7,6% | |
| 2025-12-08 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -13,759 | 87.37 | -1,202,138.96 | -45,0% | |
| 2025-12-08 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -18,357 | 88.02 | -1,615,810.68 | -60,5% | |
| 2025-12-08 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -3,929 | 89.43 | -351,356.33 | -13,2% | |
| 2025-12-08 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -8,562 | 90.12 | -771,629.70 | -28,9% | |
| 2025-10-29 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -3,627 | 61.46 | -222,906.72 | -8,3% | |
| 2025-10-29 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -1,862 | 59.72 | -111,203.30 | -4,2% | |
| 2025-10-29 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -24,511 | 61.02 | -1,495,626.90 | -56,0% | |
| 2025-10-15 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -8,963 | 61.49 | -551,160.86 | -20,6% | |
| 2025-10-15 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -29,264 | 60.37 | -1,766,667.68 | -66,2% | |
| 2025-10-15 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -14,896 | 62.72 | -934,326.28 | -35,0% | |
| 2025-10-15 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -6,453 | 63.09 | -407,099.12 | -15,2% | |
| 2025-10-13 | Albers Jeffrey W. | Director | Open Market Sale | -5,000 | 59.19 | -295,949.00 | -11,1% | |
| 2025-10-13 | Gollob Jared | Officer, Chief Medical Officer | Open Market Sale | -3,114 | 60.00 | -186,840.00 | -7,0% | |
| 2025-10-13 | Albers Jeffrey W. | Director | Open Market Sale | -5,000 | 59.19 | -295,949.00 | -11,1% | |
| 2025-09-17 | Jacobs Bruce N. | Officer, Chief Financial Officer | Open Market Sale | -79,220 | 50.00 | -3,961,380.26 | -148,4% | |
| 2025-09-16 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -30,000 | 49.00 | -1,470,000.00 | -55,1% | |
| 2025-06-30 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 600,309 | 44.00 | 26,413,596.00 | +989,4% | |
| 2025-06-30 | BVF PARTNERS L P/IL | Director | Open Market Purchase | 115,783 | 44.00 | 5,094,452.00 | +190,8% | |
| 2025-06-30 | BVF PARTNERS L P/IL | Director | Open Market Purchase | 142,604 | 44.00 | 6,274,576.00 | +235,0% | |
| 2025-06-30 | BAKER BROS. ADVISORS LP | Director | Open Market Purchase | 55,191 | 44.00 | 2,428,404.00 | +91,0% | |
| 2025-06-30 | BVF PARTNERS L P/IL | Director | Open Market Purchase | 58,780 | 44.00 | 2,586,320.00 | +96,9% | |
| 2025-06-11 | Ridloff Elena | Director | Open Market Sale | -4,500 | 50.00 | -225,000.00 | -8,4% | |
| 2025-06-03 | Esposito Pamela | Director | Open Market Sale | -5,000 | 49.04 | -245,185.50 | -9,2% | |
| 2025-06-03 | Ridloff Elena | Director | Open Market Sale | -4,800 | 47.00 | -225,600.00 | -8,5% | |
| 2025-06-03 | Mainolfi Nello | Director, Officer, Chief Executive Officer | Open Market Sale | -30,000 | 49.00 | -1,470,000.00 | -55,1% | |
| 2025-06-03 | Albers Jeffrey W. | Director | Open Market Sale | -6,349 | 49.00 | -311,101.00 | -11,7% | |
| 2025-06-03 | Albers Jeffrey W. | Director | Open Market Sale | -6,349 | 49.00 | -311,101.00 | -11,7% | |
| 2025-06-03 | Ridloff Elena | Director | Open Market Sale | -7,200 | 45.50 | -327,600.00 | -12,3% | |
| 2025-05-23 | Chadwick Jeremy G | Officer, Chief Operating Officer | Open Market Sale | -2,575 | 29.30 | -75,435.66 | -2,8% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.